Literature DB >> 33430865

TIMELESS inhibits breast cancer cell invasion and metastasis by down-regulating the expression of MMP9.

Bowen Li1, Liying Mu1, Yanan Li1, Kangkai Xia1, Yuxi Yang1, Sattout Aman1, Bashir Ahmad1, Shujing Li2, Huijian Wu3.   

Abstract

Breast cancer is the first killer leading to female death, and tumor metastasis is one of the important factors leading to the death of patients, but the specific mechanism of breast cancer metastasis is not very clear at present. Our study showed that overexpression of TIMELESS could significantly inhibit the invasion and metastasis of breast cancer cells ZR-75-30 and the assembly of F-actin protein. On the contrary, knockdown of TIMELESS promoted the invasion and metastasis of breast cancer cells. Further study revealed that TIMELESS overexpression decreased the mRNA and protein levels of MMP9. Furthermore, TIMELESS could interact with p65, leading to repress the association of p65 and its acetyltransferase CBP and down-regulating the acetylation level of p65, which inhibited the activation of NF-κB signal pathway. In conclusion, our research showed that TIMELESS may repress the invasion and metastasis of breast cancer cells via inhibiting the acetylation of p65, inhibiting the activation of NF-κB, thus down-regulating the expression of MMP9, and then inhibiting the invasion and metastasis of breast cancer cells.

Entities:  

Keywords:  Breast cancer; Invasion; MMP9; Metastasis; TIMELESS

Year:  2021        PMID: 33430865      PMCID: PMC7798230          DOI: 10.1186/s12935-021-01752-y

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  37 in total

Review 1.  FOXK transcription factors: Regulation and critical role in cancer.

Authors:  Ying Liu; Wei Ding; Hu Ge; Murugavel Ponnusamy; Qiong Wang; Xiaodan Hao; Wei Wu; Yuan Zhang; Wanpeng Yu; Xiang Ao; Jianxun Wang
Journal:  Cancer Lett       Date:  2019-05-24       Impact factor: 8.679

2.  Protumorigenic role of Timeless in hepatocellular carcinoma.

Authors:  Nahla Elgohary; Rossella Pellegrino; Olaf Neumann; Heba M Elzawahry; Magdy M Saber; Ahmed A Zeeneldin; Robert Geffers; Volker Ehemann; Peter Schemmer; Peter Schirmacher; Thomas Longerich
Journal:  Int J Oncol       Date:  2014-11-14       Impact factor: 5.650

3.  Breast cancer statistics, 2019.

Authors:  Carol E DeSantis; Jiemin Ma; Mia M Gaudet; Lisa A Newman; Kimberly D Miller; Ann Goding Sauer; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-10-02       Impact factor: 508.702

Review 4.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

5.  Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.

Authors:  S Sillanpää; M Anttila; K Voutilainen; K Ropponen; T Turpeenniemi-Hujanen; U Puistola; R Tammi; M Tammi; R Sironen; S Saarikoski; V-M Kosma
Journal:  Gynecol Oncol       Date:  2006-10-10       Impact factor: 5.482

6.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Authors:  Z S Zeng; Y Huang; A M Cohen; J G Guillem
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

7.  Human Tim-Tipin complex affects the biochemical properties of the replicative DNA helicase and DNA polymerases.

Authors:  Won-Ho Cho; Young-Hoon Kang; Yun-Young An; Inger Tappin; Jerard Hurwitz; Joon-Kyu Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

8.  TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival.

Authors:  Kenya Yoshida; Mitsuo Sato; Tetsunari Hase; Momen Elshazley; Ryo Yamashita; Noriyasu Usami; Tetsuo Taniguchi; Kohei Yokoi; Shigeo Nakamura; Masashi Kondo; Luc Girard; John D Minna; Yoshinori Hasegawa
Journal:  Cancer Sci       Date:  2013-01-07       Impact factor: 6.716

9.  Timeless Interacts with PARP-1 to Promote Homologous Recombination Repair.

Authors:  Si Xie; Oliver Mortusewicz; Hoi Tang Ma; Patrick Herr; Randy Y C Poon; Randy R Y Poon; Thomas Helleday; Chengmin Qian
Journal:  Mol Cell       Date:  2015-09-03       Impact factor: 17.970

10.  DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis.

Authors:  F Zhao; M Wang; S Li; X Bai; H Bi; Y Liu; X Ao; Z Jia; H Wu
Journal:  Oncogenesis       Date:  2015-03-16       Impact factor: 7.485

View more
  3 in total

1.  MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.

Authors:  Fangfang Li; Chen Zhao; Yuchao Diao; Zixiang Wang; Jiali Peng; Ning Yang; Chunping Qiu; Beihua Kong; Yingwei Li
Journal:  Cell Death Dis       Date:  2022-06-17       Impact factor: 9.685

2.  Loss of circadian gene Timeless induces EMT and tumor progression in colorectal cancer via Zeb1-dependent mechanism.

Authors:  Lina Sabatino; Fabrizio Bianchi; Gianluigi Mazzoccoli; Tommaso Colangelo; Annalucia Carbone; Francesco Mazzarelli; Roberto Cuttano; Elisa Dama; Teresa Nittoli; Jacopo Albanesi; Giovannina Barisciano; Nicola Forte; Orazio Palumbo; Paolo Graziano; Alessandra di Masi; Vittorio Colantuoni
Journal:  Cell Death Differ       Date:  2022-01-15       Impact factor: 12.067

3.  TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer.

Authors:  Xin Xing; Fei Gu; Lanyu Hua; Xiaoxiao Cui; Dongxue Li; Zhiyong Wu; Rong Zhang
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.